# Brink's U.S. — Hazardous Materials Safety Interpretation

**Citation:** 03-0139  
**Type / status:** guidance / guidance  
**Agency:** Pipeline and Hazardous Materials Safety Administration  
**Effective:** Not stated  
**Published:** 2003-06-24

03-0139 response to Brink's U.S. concerning 173.134.

## Document text

<<<PAGE 1>>>

of Transportation
J.S. Departmeni
JUN 24 2003
400 Seventh St., S.W.
• Washington, D.C. 20590
dministratior
Mr. Stan Turbyfill
Director of Safety
Ref. No: 03-0139
Brink's U.S.
555 Dividend Drive, Suite 100
Coppell, Texas 75019-4959
Dear Mr. Turbyfill:
This is in response to your June 2, 2003 letter asking whether currency collected from banks that
has been contaminated by a variety of substances (e.g., blood, body fluids, sewage, dye pack
chemical, etc.) would be regulated as an infectious substance under the Hazardous Materials
Regulations (HMR; 49 CFR Parts 171-180). You state that your company has no reason to
believe this currency, which is transported to the Federal Reserve for destruction, meet the
definition in § 173.134 for an infectious substance.
As you state, the HMR define an "infectious substance" in § 173.134 as a material known to
contain or suspected of containing a pathogen that has the potential to cause disease in humans or
animals. Therefore, based on the information you provided, the soiled currency do not meet the
definition of an infectious substance in § 173.134 because there is no reason to know or strongly
suspect the currency contain an infectious substance.
I hope this satisfies your request.
Sincerely,
Hother. Mitchel
Hattie L. Mitchell, Chief
Regulatory Review and Reinvention
Office of Hazardous Materials Standards
173.134
030139

<<<PAGE 2>>>

Betts
5173.134
Infectiousdubtances
IIIIBRINKS
Brink's U.S.
03-0139
A Division of Brink's, Incorporated
Suite 100
555 Dividend Drive
Tel: (469) 549-6033
Coppell, Texas 75019-4959
Stan Turbyfill
Fax: (469) 549-6232
Director of Safety
A Subsidiary of The Pittston Company
June 2, 2003
Subject:
Interpretation on Contaminated Currency and Infectious Substance Classification
Currency Contaminated with Human Blood or Body Fluids
Dear Sir or Madam:
On occasion banks receive currency that has been mutilated or contaminated by a variety of substances. The most
chemicals or other substances that make the currency unsuitable for circulation. The bank personnel usually remove the
common contaminants are blood, body fluids, sewage, and dye pack chemical, while less frequent items are water, mold
"contaminated currency" and double bag it in heavy-duty, tamper-resistant, clear plastic security bags. The bags in turn are
We believe these shipments do not meet the definition of infectious substance (class 6.2) under 49 CFR 173.134.
We base our conclusion on the following facts:
• We have no reason to believe or suspect that the blood or bodily fluids or other contaminants would cause any severe,
• We have no reason to suspect that any of the blood or contaminants contained any agent listed in 42 CFR 72.3
disabling or fatal disease;
• The blood/fluids were not prepared or manufactured in accordance with 9 CFR or 21 CFR regarding biologic or drug
• We are not shipping the contaminated currency for diagnostic purposes;
• The contaminated currency appears to meet conditions consistent with other exceptions of Division 6.2 materials
• The potential exposure is minimal due to the airtight, tamper resistant sealed double-bag packaging.
granted per 173.134 (b).
Furthermore, We believe that it is in the interest of public safety for "Contaminated Currency" to be shipped under armed
escort to prevent theft and reintroduction into circulation.
Please let us know if you concur with our assessment of this situation.
He Tubje
Stan Turbyfill
Director of Safety

## Provenance

- Official: Yes
- Source: <https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretation%20Files/2003/030139.pdf>
- Source ID: `phmsa`
- SHA-256: `f31f17756ba513bc1f5980304357792f5019418bbe56d5521f600afff4443e30`
- Retrieved: 2026-08-20T00:59:31.977Z
- Exported: 2026-08-23T02:26:24.567Z
- Document slug: `phmsa-interpretation-03-0139`

### Source metadata

```json
{
  "materialSubtype": "interpretation",
  "interpretationArea": "hazardous_materials",
  "representation": "full_text_from_official_pdf",
  "companies": [
    "Brink's U.S."
  ],
  "individuals": [
    "Mr. Stan Turbyfill"
  ],
  "refIds": [
    "03-0139"
  ],
  "catalogDates": [
    "2003-06-24"
  ],
  "catalogParts": [
    173
  ],
  "catalogRowCount": 1,
  "sourceRecordUrls": [
    "https://www.phmsa.dot.gov/node/68781"
  ],
  "linkedAttachmentUrls": [],
  "unavailableResponseUrls": [],
  "duplicateRepresentationUrls": [],
  "citedSections": [
    "173.134"
  ],
  "catalogPageUrls": [
    "https://www.phmsa.dot.gov/regulations/title49/section/173134"
  ],
  "pdfUrls": [
    "https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretation%20Files/2003/030139.pdf"
  ],
  "representations": [
    {
      "viewUrl": "https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretation%20Files/2003/030139.pdf",
      "detailUrl": null,
      "detailHtmlPath": null,
      "pdfUrl": "https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretation%20Files/2003/030139.pdf",
      "pdfArtifactPath": "data/sources/phmsa-interpretations/03-0139-81e1fc2308.pdf",
      "pdfArtifactSha256": "afb6105cd9b8628411b28894f44f88217d4364ad89024bebbe91b96e81225bef",
      "extractedTextPath": "data/sources/phmsa-interpretations/03-0139-81e1fc2308.v2.txt",
      "extractedTextSha256": "d2be214d9893669b41d1ef141ad0b4b68c37727d6f1fd25fc8e842b73e98a79d",
      "pageCount": 2,
      "extractionVersion": 2
    }
  ],
  "caveat": "Interpretations apply regulations to the facts presented and do not create independently enforceable requirements.",
  "jurisdiction": "US"
}
```
